Annual Operating Margin
-190.01 K%
-189.79 K%-85918.45%
31 December 2023
Summary:
Lyell Immunopharma annual operating profit margin is currently -190.01 thousand%, with the most recent change of -189.79 thousand% (-85918.45%) on 31 December 2023. During the last 3 years, it has fallen by -187.27 thousand% (-6853.41%). LYEL annual operating margin is now -85918.45% below its all-time high of -220.89%, reached on 31 December 2022.LYEL Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-148.54 K%
+247.83 K%+62.52%
30 September 2024
Summary:
Lyell Immunopharma quarterly operating profit margin is currently -148.54 thousand%, with the most recent change of +247.83 thousand% (+62.52%) on 30 September 2024. Over the past year, it has increased by +87.61 thousand% (+37.10%). LYEL quarterly operating margin is now -486132.80% below its all-time high of -30.55%, reached on 31 December 2022.LYEL Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -10000.0% | +37.1% |
3 y3 years | -6853.4% | -8224.5% |
5 y5 years | - | - |
LYEL Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | <-9999.0% | at low | <-9999.0% | +93.3% |
5 y | 5 years | <-9999.0% | at low | <-9999.0% | +93.3% |
alltime | all time | <-9999.0% | at low | <-9999.0% | +93.3% |
Lyell Immunopharma Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -148.54 K%(-62.5%) |
June 2024 | - | -396.37 K%(-78.6%) |
Mar 2024 | - | -1.85 M%(+304.7%) |
Dec 2023 | -190.01 K%(>+9900.0%) | -457.75 K%(+93.8%) |
Sept 2023 | - | -236.16 K%(-3.3%) |
June 2023 | - | -244.09 K%(+153.6%) |
Mar 2023 | - | -96.24 K%(>+9900.0%) |
Dec 2022 | -220.89% | -30.55%(-100.0%) |
Sept 2022 | - | -2.21 M%(>+9900.0%) |
June 2022 | - | -104.25%(-99.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -12.40 K%(+636.1%) |
Dec 2021 | -2016.68%(-26.2%) | -1684.55%(-5.6%) |
Sept 2021 | - | -1784.43%(-25.2%) |
June 2021 | - | -2386.11%(+5.4%) |
Mar 2021 | - | -2264.62%(+32.5%) |
Dec 2020 | -2732.56%(-82.4%) | - |
Dec 2020 | - | -1709.52%(-50.4%) |
Sept 2020 | - | -3443.27%(+4.7%) |
June 2020 | - | -3289.48%(+25.2%) |
Mar 2020 | - | -2627.71% |
Dec 2019 | -15.54 K% | - |
FAQ
- What is Lyell Immunopharma annual operating profit margin?
- What is the all time high annual operating margin for Lyell Immunopharma?
- What is Lyell Immunopharma annual operating margin year-on-year change?
- What is Lyell Immunopharma quarterly operating profit margin?
- What is the all time high quarterly operating margin for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly operating margin year-on-year change?
What is Lyell Immunopharma annual operating profit margin?
The current annual operating margin of LYEL is -190.01 K%
What is the all time high annual operating margin for Lyell Immunopharma?
Lyell Immunopharma all-time high annual operating profit margin is -220.89%
What is Lyell Immunopharma annual operating margin year-on-year change?
Over the past year, LYEL annual operating profit margin has changed by -189.79 K% (-85918.45%)
What is Lyell Immunopharma quarterly operating profit margin?
The current quarterly operating margin of LYEL is -148.54 K%
What is the all time high quarterly operating margin for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly operating profit margin is -30.55%
What is Lyell Immunopharma quarterly operating margin year-on-year change?
Over the past year, LYEL quarterly operating profit margin has changed by +87.61 K% (+37.10%)